
Reset all filters
01 2Krystexxa
Main Therapeutic Indication : Rheumatology
Currency : USD
2023 Revenue in Millions : 272
2022 Revenue in Millions : 0
Growth (%) : Acquired from Horizon
Main Therapeutic Indication : Rheumatology
Currency : USD
2024 Revenue in Millions : 1,185
2023 Revenue in Millions : 272
Growth (%) : 336